Braf V600E mutant solid tumors, FDA ok a combination of therapies – medicine

(ANSA) – ROME – Breakthrough in Cancer Treatment. The Food and Drug Administration (FDA) has approved the combined use of dabrafenib (Tafinlar) plus trametinib (Mekinist) for the treatment of adult and pediatric patients 6 years of age and older with unresectable or metastatic solid tumors harboring a BRAF V600E mutation. A decision that is revolutionizing … Read more

“My battle with cancer has begun” – Libero Quotidiano

Giovanni Allevi, after announcement on his profile Instagram A… have multiple myelomareturns to social media with a new post announcing that the way of care to fight against Cancer and thanks his fans for the affection and closeness they have shown him. “With a heart overflowing with gratitude,” writes the pianist and composer, “I thank … Read more

Horoscope of the week from June 20th to 26th, 2022

With the summer solstice of this week we begin the season of Cancer: with the Sun in this water sign we can get closer to home and our needs, but in general this week’s astrology tells of a creative and dynamic dimension. Not only on Monday does Mercury and Jupiter speak in unison of a … Read more

Myeloma multimo, what is the disease that struck Giovanni Allevi?

Giovanni Allevi explained on social media that he suffers from it myeloma, a particularly insidious disease. It can manifest with many symptoms and signs, so much so that it can sometimes start with bone crushing pain or severe back pain. Therefore, some people experience unexplained fractures, kidney problems, infections. In short, it is difficult to … Read more

Tumors: Effective Drugs for Rare Molecular Mutations – Medicine

(ANSA) — CHIETI, June 17 — A new diagnostic strategy based on tissue arrays allows rapid selection of patients with different tumor types to detect the presence of rare molecular changes: tumors are taken, a fragment taken and in a regular manner Order arranged the same support to analyze them together inexpensively and quickly. With … Read more